ITOLIZUMAB
UNII XQQ2RHV14N

Substance Identification & Data

This profile provides standardized clinical and technical data for Itolizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XQQ2RHV14N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1116433-11-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XQQ2RHV14N

CAS Registry Number

1116433-11-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ITOLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C95787

National Cancer Institute reference terminology for clinical and research data.

INN ID

9321

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-88

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Itolizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ITOLIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN ANTIGEN CD6) (HUMAN-MOUSE MONOCLONAL T1H HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL T1H LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD6 (TP120, T12)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-449) (HUMANIZED VH (HOMO SAPIENS IGHV3-21*08 (83.70%) -(IGHD)-IGHJ5*01) (8.8.12) (1-119)-HOMO SAPIENS IGHG1*01 (120-449)), (222-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-17*01 (76.80%)-IGKJ2*01 F118>L, Q120>S) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')); (228-228:231-231)-BISDISULFIDE DIMER

ITOLIZUMAB [INN]

ITOLIZUMAB [USAN]

ITOLIZUMAB [WHO-DD]